drugset / Trial / NCT07806630
SHORTened Duration of TAMoxifen
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to learn whether a shorter-duration, low-dose tamoxifen regimen can reduce the risk of developing breast cancer or breast cancer recurrence in post-menopausal women who are at increased risk for breast cancer.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2028-07
- Completion
- 2029-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 10 mg | Oral |